Position in AVXL
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$183,967
-$182,821 QoQ
Shares Held
71,030
-40.5% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 13 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $26,828,326 across 11 Biotechnology names. AVXL ranks #10 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MNKD |
Mannkind Corp
|
4,959,351 | $21,126,835 | |
| 2 | MRNA |
Moderna, Inc.
|
35,750 | $2,503,572 | |
| 3 | INCY |
Incyte Corp
|
7,045 | $798,621 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
190,562 | $699,362 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
7,257 | $395,796 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
8,753 | $341,454 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
548 | $272,208 | |
| 8 | EXEL |
Exelixis, Inc.
|
4,266 | $232,113 |
All Filings in AVXL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,967 | 71,030 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $366,788 | 119,475 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $417,872 | 117,380 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $383,011 | 43,035 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $406,141 | 44,050 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $120,591 | 14,055 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||